NEW YORK (GenomeWeb News) – NanoString Technologies reported after the close of the market Wednesday a 55 percent increase in fourth quarter revenues, driven by strong growth for its instruments.

The Seattle-based genetic analysis systems maker reported total revenues of $10.1 million for the three months ended Dec. 31, up from $6.5 million year over year. NanoString beat analysts' consensus estimate for revenues of $9.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.